Patents for C12N 5 - Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor (182,629)
07/2009
07/07/2009US7557083 Gastrokines and derived peptides including inhibitors
07/07/2009US7557078 Morphogen-induced nerve regeneration and repair
07/07/2009US7556965 Structural protein of adeno-associated virus with modified antigenicity, its production and its use
07/07/2009US7556964 Transgenic cell and gene recombinant animal having a mutant SDHC gene derived from mammals
07/07/2009US7556957 Attenuated virus-like particle for use as gene transfer tool in treatment and prevention of metabolic disorders; tissue target therapy
07/07/2009US7556955 Nucleic acids encoding Candida kefyr cytosine deaminase
07/07/2009US7556953 Nucleic acid encoding a novel ribonuclease having an amino acid sequence made up of the amino acid sequence of a known ribonuclease and an N-terminal leader sequence
07/07/2009US7556952 Nucleic acid encoding a novel ribonuclease having an amino acid sequence made up of a known amino acid sequence and an initial N-terminal residue
07/07/2009US7556951 Bioactive ribonucleases for treating tumors in humans
07/07/2009US7556944 Methods and compositions for use in preparing siRNAs
07/07/2009US7556941 Comprises fusion protein comprising platelet derived growth factor for treating connective tissue, tumor and bone disorders; used to stimulate the production of bone and/or connective tissue in both humans and non-human animals
07/07/2009US7556940 Assembly of wild-type and chimeric influenza virus-like particles (VLPs)
07/07/2009US7556938 Nucleic acids encoding potassium channel interactors
07/07/2009US7556815 Mutant viral antigen for use in diagnosing hepatitis; immunoassay
07/07/2009US7556804 Monoclonal antibodies which recognize the chain of hepatocyte growth factor receptor (HGF) receptor with the agonist activity of the natural ligand; hybridoma and the antibodies it secretes; inhibiting apoptotic damage to cells ; cardioprotective and hepatoprotective drugs
07/07/2009US7556801 Pluripotent somatic stem cells for use in regenerative medicine; use in treatment of vascular disease, Parkinson's disease, diabetes
07/07/2009CA2405518C Compounds, compositions and methods for preventing neurodegeneration in acute and chronic injuries in the central nervous system
07/07/2009CA2306794C Cleaning compositions containing multiply-substituted protease variants
07/07/2009CA2201161C Isolated nucleic acid molecule coding for tumor rejection antigen precursor dage and uses thereof
07/07/2009CA2168029C Prosaposin and cytokine-derived peptides as therapeutic agents
07/07/2009CA2167692C Method for diagnosing a disorder by determining expression of gage tumor rejection antigen precursors
07/02/2009WO2009081955A1 Component protein pa1698 for type-iii secretion system of pseudomonas aeruginosa
07/02/2009WO2009081254A1 Cells belonging to the adaptive immune system that express paq isoform of tmem126b
07/02/2009WO2009080914A2 Method for stimulating the proliferation of differentiated cells belonging to the chondrogenic lineage
07/02/2009WO2009080794A1 Method for preparing cell-specific extracellular matrices
07/02/2009WO2009080759A1 Organic compounds
07/02/2009WO2009080749A1 Human bone-forming cells in the treatment of inflammatory rheumatic diseases
07/02/2009WO2009080299A1 Sm-protein based secretion engineering
07/02/2009WO2009079775A1 Composition for supporting heat shock protein function comprising glutamine
07/02/2009WO2009060402A3 Plant promoters of the xvsap1 gene
07/02/2009WO2009053631A3 Method for optimizing blood cell transplants
07/02/2009WO2009053629A3 Treatment of tumours using t lymphocyte preparations
07/02/2009WO2009042639A3 Method for creating perfusable microvessel systems
07/02/2009WO2009029315A3 Inducible mutagenesis of target genes
07/02/2009WO2009020596A3 Embryonic cerebrospinal fluis (e-csf), proteins from e-csf, and related methods and compositions
07/02/2009WO2008058380A8 Cancerous disease modifying antibodies
07/02/2009US20090172845 Gray leaf spot tolerant maize and methods of production
07/02/2009US20090172844 Engineering single-gene-controlled staygreen potential into plants
07/02/2009US20090172843 Specific Promoter Region Expresses in Actively Dividing Young Tissues and the Aging Tissues in Plants as Well as its Application
07/02/2009US20090172840 Nucleotide sequences and corresponding polypeptides conferring an altered flowering time in plants
07/02/2009US20090172835 Flax (linum usitatissimum l.) seed-specific promotors
07/02/2009US20090172834 Proteins Associated With Abiotic Stress Response And Homologs
07/02/2009US20090172832 Expression of rubisco enzyme from a non-rubisco locus
07/02/2009US20090172831 Methods for the production of plants resistant to HPPD herbicides
07/02/2009US20090171077 Delivery of nucleic acid-like compounds
07/02/2009US20090170960 Peptide lipid-containing carrier and method for introducing compound into cells using same
07/02/2009US20090170866 Moesin, caveolin 1 and yes associated protein 1 as predictive markers of response to dasatinib in breast cancers
07/02/2009US20090170865 Treatment of Prostate Cancer with Angiogenesis-Targeting Quinazoline-Based Anti-Cancer Compounds
07/02/2009US20090170842 Brca1-based breast or ovarian cancer prevention agents and methods of use
07/02/2009US20090170800 Genetic constructs and compositions comprising rre and cte and uses thereof
07/02/2009US20090170796 Histone Demethylation Mediated By The Nuclear Amine Oxidase Homolog LSD1
07/02/2009US20090170793 Theophylline-dependent riboswitches which modulate RNA splicing; made by insertion of a high affinity theophylline binding aptamer into the 3' splice site region, 5' splice site region, or branchpoint sequence (BPS) of a pre-mRNA modulates RNA splicing in the presence of theophylline
07/02/2009US20090170775 Vasoactive intestinal polypeptide compositions
07/02/2009US20090170769 Cell surface receptor isoforms and methods of identifying and using the same
07/02/2009US20090170767 Soluble Endoglin Compounds for the Treatment and Prevention of Cancer
07/02/2009US20090170763 Modified gherlin peptides
07/02/2009US20090170759 Neuroprotective peptides
07/02/2009US20090170754 Treating liver diseases
07/02/2009US20090170751 Formation of superfibronectin by BBK32 and uses therefor
07/02/2009US20090170750 Single-Chain Insulin
07/02/2009US20090170205 Method of maintenance and expansion of hematopoietic stem cells
07/02/2009US20090170202 Nucleic acids that enhance the synthesis of 2-acetyl-1-pyrroline in plants and fungi
07/02/2009US20090170201 Compositions and methods of making embryonic stem cells
07/02/2009US20090170200 Stem cell medium
07/02/2009US20090170199 Separation and sorting of different biological objects
07/02/2009US20090170198 Differentiation of human embryonic stem cells
07/02/2009US20090170197 Nucleic Acid-Mediated Treatment of Diseases or Conditions Related to Levels of Vascular Endothelial Growth Factor Receptor (VEGF-R)
07/02/2009US20090170196 Cancer treatment using c-type natriuretic peptide
07/02/2009US20090170195 Curcumin-hyaluronan compounds
07/02/2009US20090170194 Teal fluorescent proteins
07/02/2009US20090170193 Stem cells
07/02/2009US20090170192 Methods and dna constructs for high yield production of polypeptides
07/02/2009US20090170191 84p2a9: a prostate and testis specific protein highly expressed in prostate cancer
07/02/2009US20090170182 Lopap-based pharmaceutical compositions and uses thereof
07/02/2009US20090170181 EGVII Endoglucanase and Nucleic Acids Encoding The Same
07/02/2009US20090170173 Nucleic acid molecules encoding polypeptides involved in regulation of sugar and lipid metabolism and methods of use viii
07/02/2009US20090170172 Recombinant Methods and Materials for Producing Epothilone and Epothilone Derivatives
07/02/2009US20090170165 Method for recombinant production in cho cells
07/02/2009US20090170162 Non-coiled protective regions of pneumococcal surface proteins pspa and pspc
07/02/2009US20090170161 GDEP Enhancer Element and Use Thereof to Confer Retinal Specific Gene Expression
07/02/2009US20090170160 Expression System
07/02/2009US20090170158 Secreted and transmembrane polypeptides and nucleic acids encoding the same
07/02/2009US20090170156 Hydroxynitrile lyase
07/02/2009US20090170148 Nanog+, OCT-4+ Retinal Pigment Epithelial Stem Cells and Methods for Their Use and Manufacture
07/02/2009US20090170146 Novel Carboxylesterase Nucleic Acid Molecules, Proteins and Uses Thereof
07/02/2009US20090170141 Ghrelin o-acyltransferase (goat) biochemical assay
07/02/2009US20090170122 Human intestinal NPT2B
07/02/2009US20090170101 Identification of thymically derived cd4 t cells by protein tyrosine kinase 7 expression
07/02/2009US20090170099 Use of Regulatory Sequences for Specific, Transient Expression in Neuronal Determined Cells
07/02/2009US20090170098 Antibodies to cell-cycle regulatory protein p16, and uses related thereto
07/02/2009US20090170095 Mnk KINASE HOMOLOGOUS PROTEINS INVOLVED IN THE REGULATION OF ENERGY HOMEOSTASIS AND ORGANELLE METABOLISM
07/02/2009US20090170093 Selection marker system and method for screening a choline tolerant plant cell
07/02/2009US20090170067 Simian tropic, recombinant human immunodeficiency-1 viruses
07/02/2009US20090170063 Hcv rna having novel sequence
07/02/2009US20090170061 Device comprising a sample of reconstructed tissue and a detection system
07/02/2009US20090170059 Methods for Preparing Cord Matrix Stem Cells (CMSC) for Long Term Storage and for Preparing a Segment of umbilical cord for cryopreservation
07/02/2009US20090169709 Promoter molecules for use in plants
07/02/2009US20090169658 Toona sinensis extract for suppressing proliferation and inducing apoptosis of osteosarcoma cells
07/02/2009US20090169649 Treatment of neurodegenerative diseases
07/02/2009US20090169642 Reconstructed living adipose tissue